[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kyogoku et al., 2013 - Google Patents

Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?

Kyogoku et al., 2013

View HTML
Document ID
13265305452681688127
Author
Kyogoku C
Smiljanovic B
Grün J
Biesen R
Schulte-Wrede U
Häupl T
Hiepe F
Alexander T
Radbruch A
Grützkau A
Publication year
Publication venue
PloS one

External Links

Snippet

Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE). However, it is unclear how particular leucocyte subsets contribute to the overall type I …
Continue reading at journals.plos.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Similar Documents

Publication Publication Date Title
Kyogoku et al. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Xu et al. The transcription factor Tox2 drives T follicular helper cell development via regulating chromatin accessibility
Comabella et al. A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
Pidasheva et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q
Gren et al. A single-cell gene-expression profile reveals inter-cellular heterogeneity within human monocyte subsets
Herrera-Uribe et al. Reference transcriptomes of porcine peripheral immune cells created through bulk and single-cell RNA sequencing
Michlmayr et al. Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases
Wei et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration
Psarras et al. TNF-α regulates human plasmacytoid dendritic cells by suppressing IFN-α production and enhancing T cell activation
He et al. PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells
Stegemann-Koniszewski et al. Alveolar type II epithelial cells contribute to the anti-influenza A virus response in the lung by integrating pathogen-and microenvironment-derived signals
Piovesan et al. c-Myb regulates the T-bet-dependent differentiation program in B cells to coordinate antibody responses
Yun et al. Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells
Zhang et al. Single‐cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis
Boyd et al. Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection
Prokop et al. High-density blood transcriptomics reveals precision immune signatures of SARS-CoV-2 infection in hospitalized individuals
Chemin et al. EOMES‐positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers
Aso et al. Comparative description of the expression profile of interferon-stimulated genes in multiple cell lineages targeted by HIV-1 infection
Seo et al. IL-15 enhances CCR5-mediated migration of memory CD8+ T cells by upregulating CCR5 expression in the absence of TCR stimulation
Kol et al. Th17 pathway as a target for multipotent stromal cell therapy in dogs: implications for translational research
Cavagnero et al. Unconventional ST2-and CD127-negative lung ILC2 populations are induced by the fungal allergen Alternaria alternata
Grieshaber-Bouyer et al. Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint
Kondo et al. HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases
Islam et al. PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig
Li et al. A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity